Table 1.

Distribution of patients’ characteristics

	Whole sample (N = 2743)		Women (N = 1424)		Men (N = 1319)		P b
	N	%a	N	%a	N	%a
Sex
Women	1424	51.6
Men	1319	48.4
Age
55‐65	720	32.4	366	31.7	354	33.1	0.547
65‐80	1545	49.6	802	49.5	743	49.7
80+	478	18.0	256	18.8	222	17.2
Number of anti‐HTN tablets
1	1600	58.2	879	61.3	721	54.9	0.001
2	629	23.4	291	21.1	338	25.9
3+	229	8.2	102	7.0	127	9.4
NA	285	10.2	152	10.6	133	9.8
Number of tablets taken for metabolic diseases
0	1278	46.1	731	50.7	547	41.1	<10−4
1	1116	41.1	549	39.1	567	43.3
2	349	12.8	144	10.2	205	15.6
History of cardiovascular diseases
No	2091	76.2	1184	83.2	907	68.8	<10−4
Yes	652	23.8	240	16.8	412	31.2
Number of other chronic diseases
0	872	31.7	367	25.6	505	38.1	<10−4
1	1284	46.7	683	47.8	601	45.6
2+	587	21.6	374	26.6	213	16.3
Contact with health care
Low	381	14.0	207	14.7	174	13.3	<10−4
Intermediate	1284	46.8	730	50.8	554	42.5
High	992	35.9	443	31.3	549	40.6
NA	86	3.3	44	3.1	42	3.5
Copayment
Yes	636	23.1	394	27.7	242	18.2	<10−4
No	2091	76.3	1021	71.7	1070	81.2
NA	16	0.6	9	0.6	7	0.6

Anti‐HTN, antihypertensive.

^aWeighted percentages

^b P comparing women to men, complete case analyses